Professor Keith Klugman – Prevention of Influenza Mortality By Controlling Secondary Bacterial Infections

Event date
Monday 18th February 2019
Event time
12:00 PM
Event address
Berg Family Foundation Seminar Room, Level 6, Wallace Wurth Building, Kensington Campus, UNSW Sydney

Location:

Berg Family Foundation Seminar Room, Level 6, Wallace Wurth Building, Kensington Campus, UNSW Sydney

 

A catered lunch will be provided at 1:00pm. Please RSVP to recpt@kirby.unsw.edu.au by COB Thursday 14 February.

Kirby Institute and PLuS Alliance logos

Kirby Institute Seminar Series presents

Professor Keith Klugman  

Professor Keith Klugman

Pneumonia Program Director, Bill & Melinda Gates Foundation, USA

About your speaker

Professor Keith Klugman leads the Gates Foundation’s work to reduce deaths from pneumonia, neonatal sepsis, and meningitis in children. His work demonstrating pneumococcal conjugate vaccine efficacy in the developing world has led to interventions that have saved millions of lives, especially in Africa.

Abstract

Both pandemic and seasonal influenza continue to be associated with considerable hospitalisation and mortality. Influenza exposure in both mice and humans increases pneumococcal density and may impact pneumococcal transmission. Especially during the 1918 pandemic in the absence of antibiotics, but also during subsequent influenza pandemics, including that of 2009, there is significant evidence of a burden of influenza mortality attributable to secondary bacterial pneumonia. The role of infant immunisation with pneumococcal conjugate vaccine in mitigation of influenza hospitalisation among all ages will be discussed.

If you cannot join us on the day, you are most welcome to attend via teleconference using this link: https://global.gotomeeting.com/join/963188549